GLP-1 agonists are currently approved for three conditions: type 2 diabetes, obesity, and heart disease
Traveling with used syringes requires careful handling to avoid injuries and maintain personal and public safety
The loss of collagen is the foundation of all of these complications, even if we aren't on a diet
However, there are several case reports (ie
Common Symptoms and Warning Signs to Watch For Understanding the spectrum of symptoms associated with allergic reactions to GLP-1 agonists enables early recognition and appropriate action
Zhang Q, Li Q, Liu S, Zheng H, Ji L, Yi N et al (2022) Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia